PAVmed Inc.
360 Madison Avenue, 25th Floor
New York, New York 10017
April 27, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Margaret Sawicki
| Re: | PAVmed Inc. | |
| Registration Statement on Form S-3 | ||
| Filed April 21, 2026 | ||
| File No. 333-295202 |
Ladies and Gentlemen:
PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Wednesday, April 29, 2026, or as soon thereafter as practicable.
| Very truly yours, | ||
| PAVMED INC. | ||
| By: | /s/ Lishan Aklog, M.D. | |
| Name: | Lishan Aklog, M.D. | |
| Title: | Chairman and Chief Executive Officer | |